Education & Experience

Research & Publications ажил

• Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography. Onkologie 2013;36:169-174
• The Clinicopathological Relevance for The Expression of Secreted Protein Acidic and Rich in Cysteine in Epithelial Ovarian Tumors. Korean J Obstet Gynecol 2011; 54(12): 770-777
• The role of adjuvant therapy in FIGO stage IB-IIA cervical cancers with intermediate risk factors. Korean J Obstet Gynecol 2007:93 141~14
• Recent Clinical Review : Current status of application of the secondary cytoreductive surgery for patients with epithelial ovarian carcinomas. Korean J Obstet Gynecol 2007; 50(8): 1057-1063
• Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):794-9.
• Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
• Efficacy of fibrin sealant in reducing hemorrhage after a loop electrosurgical excision procedure. 2012;74(1): 1-5. doi: 10.1159/000333266. Epub 2012 Jun 27
• Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):219-23.
• Risk of metastatic ovarian involvement in nongynecologic malignancies. Int J Gynecol Cancer. 2012 Jan;22(1):3-8.
• Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease. J Korean Med Sci. 2010 Jul;25(7):1029-33.
• Modalities for evaluation of tumor size in cervical cancer. Choi SC, Kim K, Park SI, Kim BJ, Kim MH, Ryu SY, Lee ED, Lee KH. J Gynecol Oncol. 2008 Sep;19(3):205.
• Clinicopathologic characteristics and prognostic factors of primary peritoneal carcinoma. Korean J Obstet Gynecol 2009:52, 212~219(Korean J Obstet Gynecol (Korean J Obstet Gynecol (Korean J Obstet Gynecol.